News

Gustave Roussy Remains the No. 1 Cancer Centre in France and Europe

The excellence of Gustave Roussy has once again been recognised by the American magazine Newsweek, which has ranked the Institute as the leading cancer centre in France and in Europe, and among the very best worldwide, following the publication of the World’s Best Specialised Hospitals 2026 ranking.

Published on

Logo Word's best specialized hospitals - Newsweek

The excellence of Gustave Roussy has once again been recognised by the American magazine Newsweek, which has ranked the Institute as the leading cancer centre in France and in Europe, and among the very best worldwide, following the publication of the World’s Best Specialised Hospitals 2026 ranking.

Logo Word's best specialized hospitals - Newsweek

Published annually by Newsweek in collaboration with Statista, the World’s Best Specialised Hospitals 2026 ranking is based on the results of an online survey of tens of thousands of healthcare experts worldwide and takes into account quality indicators reported by patients.

“This ranking highlights France’s ability to shine on the scientific stage. Gustave Roussy secures its place in the world’s Top 10, at sixth position, competing with centres with vastly larger budgets, thereby demonstrating the Institute’s capacity for innovation and the talent of its teams. This result, which is a source of pride for all our staff, is also a call to strengthen public and private investment so that French research can compete with the leading American and Asian oncology centres,” says Professor Fabrice Barlesi, Chief Executive Officer of Gustave Roussy.

In this context of heightened global competition with institutions that enjoy budgets far exceeding those available in France and unparalleled human resources, Gustave Roussy’s continued presence in the world’s Top 10 – ranking first in France and first in Europe – is an exceptional achievement. It is evidence of the innovative strength and talent of French teams and of the unwavering commitment of the Institute’s staff to deliver the highest quality of care to all patients, alongside top-level research with major societal impact. Researchers and clinicians continue to work towards their goal of curing 80 % of patients with cancer by 2040.

Last news

  • Two photon-counting CT scanners now equip Gustave Roussy's imaging department

    Since September 2026, Gustave Roussy's Department of Medical Imaging has been equipped with a second photon-counting CT scanner, delivering higher image resolution while reducing the doses of X-rays and contrast agent administered to patients. This technology recently enabled the Institute to perform an iodine-free pulmonary CT angiogram, a world first.

    Photographie du scanner à comptage photonique
  • Prevention and screening: getting ahead of lung cancer

    To mark Thoracic Cancer Awareness Month and Tobacco-Free Month, two campaigns focusing on lung cancer, Gustave Roussy highlights its initiatives to advance prevention and screening among people at increased risk. Since its creation in 2021, the Institute’s Interception Lung programme has welcomed more than 900 participants, supporting them to stop smoking and offering personalised screening for the disease.

    Photographie : patient effectuant un scanner thoracique et équipes soignantes
  • Gustave Roussy Meets His Audience

    As part of its awareness-raising and fundraising efforts, Gustave Roussy is currently conducting a door-to-door outreach campaign in several towns in Val-de-Marne (Fresnes, Vitry-sur-Seine, Nogent-sur-Marne, Bry-sur-Marne, Le Kremlin-Bicêtre) from Monday through Saturday, 1:30 p.m. to 8:00 p.m.

    Deux personnes en charge de la collecte porte-à-porte
  • Mens November: Take care of your jewelry its precious!

    November is the month dedicated to raising awareness and promoting prevention of male cancers, which include prostate, testicular, and penile cancers. The goal is to raise public awareness of these diseases—which account for approximately 63,000 new cases in France each year—and to encourage men to perform testicular self-exams, a simple step that can help detect a lump, the nature of which must then be determined through further medical examinations. Gustave Roussy has extensive expertise in the treatment of male cancers, particularly through its Genitourinary Oncology Committee, which is deeply involved in research on these diseases. 

    Visuel fixe campagne novembre masculin